KRTX
Karuna Therapeutics, Inc.
Director Atul Pande sold $577K of Karuna Therapeutics, Inc.
Sold$576,550
$115.31Price
5,000Shares
−100%Stake
What KRTX did after the filing
Prices for KRTX after this filing aren't in yet.
Traded Thu, Apr 1. Filed Mon, May 3, 5:10 PM ET, after the close. Not investment advice.